Critical Limb Ischemia
210
24
26
107
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
29 trials with published results (14%)
Research Maturity
107 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.6%
16 terminated out of 210 trials
87.0%
+0.5% vs benchmark
11%
23 trials in Phase 3/4
27%
29 of 107 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 107 completed trials
Clinical Trials (210)
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Single Versus Multiple Vessels Endovascular Tibial Arteries Revascularization for Critical Limb Ischemia
Percutaneous Deep Vein Arterialization Post-Market Study
Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
PROMISE International
Nutrition in Patient With Critical Limb Ischemia
CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
Safety Study of Gene Therapy in Treating Critical Leg Ischemia
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease
Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease
A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)
Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Swedish Drug-elution Trial in Peripheral Arterial Disease
Medium-term Results of Lower Limb Arterial Bypass
Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging
IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
BEST vCLI Registry
Serrantor OCT Study